Literature DB >> 22512250

Six patients with pyoderma gangrenosum successfully treated with infliximab.

Jascha E Mooij1, Dominique C van Rappard, Jan R Mekkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22512250     DOI： 10.1111/j.1365-4632.2011.05201.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  4 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

3.  Evaluation of a Rheumatology Transition Clinic.

Authors:  Elizabeth Stringer; Rachel Scott; Dianne Mosher; Inez MacNeill; Adam M Huber; Suzanne Ramsey; Bianca Lang
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-11       Impact factor: 3.054

4.  Biologics in dermatology.

Authors:  David Chandler; Anthony Bewley
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.